For most people, a train ride home after a music festival is a time to unwind and savor the last notes of a weekend well spent. For 29-year-old Lauren Macpherson, however, a seemingly ordinary journey in August 2025 became the start of a life-altering ordeal—one that would reveal a hidden, terminal illness and propel her into a campaign for change in cancer treatment access.
Macpherson, a cardiographer from Cardiff, had just celebrated passing her exams for a work promotion and buying her first home with her boyfriend, Zak. The August bank holiday festivities in London were meant to be the "first of many" new beginnings. But fate had other plans. As she traveled back to Cardiff, a 16-kilogram (35-pound) suitcase tumbled from an overhead luggage rack, striking her head with force. The accident was jarring enough that she was taken off the train at Swindon and rushed to hospital for a CT scan to check for spinal or head injuries.
While the scans showed her spine was intact, doctors spotted something far more sinister: a shadow on her brain. Further tests, including an MRI in Cardiff, confirmed the presence of a tumor. As Macpherson later told BBC News, "It's like the floor just drops from beneath you, you don't know what to do, it's horrible." She would soon learn her life expectancy had been cut to about 10 to 12 years.
Looking back, the diagnosis made sense of a year’s worth of unexplained health struggles. Macpherson had been plagued by extreme fatigue, emotional instability, gut issues, and blackouts—symptoms that forced her to reduce her working hours just to keep up with her master’s degree studies. She had visited her GP several times, but the gradual onset and variety of symptoms led doctors to suspect hormonal changes or her then-undiagnosed ADHD. The train accident, ironically, became the catalyst that finally revealed the real cause.
"There is an instinct inside you and when you have been feeling unwell, it just all made sense," Macpherson recalled in her interview with BBC News. "It's almost like a relief, you think you're going crazy, all these things going wrong." At first, she was hopeful: "I didn't think at this point, it's incurable, I just thought 'they've found it, they can get rid of it'." But the reality soon set in. After a month-long wait to see her consultant, she was told the tumor could be glioblastoma—one of the most aggressive and deadly forms of brain cancer. "We did not expect it at all. Then it kind of hit me and that's when you're like, 'oh my god, you could be looking at two years'."
Fortunately, a biopsy revealed the tumor was a grade two oligodendroglioma—a rare, slower-growing brain tumor. While still incurable, this diagnosis offered a better prognosis: doctors estimated she could live another decade or so. The news was bittersweet. As Macpherson put it, "I was worried but at this point I wasn't scared."
With her tumor located in the speech cortex, Macpherson was told she would need major surgery. The wait for an NHS operation was four months, but she was able to expedite the process to three weeks by seeking care through a private clinic under Zak’s healthcare coverage. A spokesperson for Cardiff and Vale University Health Board explained to BBC News that cancer cases are prioritized, but Macpherson ultimately chose the private route to get faster treatment. In October 2025, surgeons successfully removed about 80% of the tumor. The aftermath, however, was grueling. She temporarily lost her ability to speak and suffered significant cognitive impairment. "It's almost like somebody had given me a new brain, it was really strange, nothing made sense, I didn't feel like me," she said. Recovery was slow, marked by sickness, vertigo, and days when she simply wanted to feel "OK" again.
Throughout this ordeal, Macpherson’s survival instinct kicked in. But she also felt the emotional toll on her loved ones. "The whole thing has been hard for me... but for family, it's almost been harder for them," she admitted. "I think everyone always says 'I wish it was me, not you' but I could really see it with them, constantly the pain in their eyes, because they wanted it to be them not me. It was really, really, hard, I wouldn't wish that on anyone, having to deal with that."
Wanting to connect with others facing similar battles, Macpherson began documenting her journey on Instagram. She uses the platform to share updates, provide support, and raise awareness about brain tumors. "You just want to talk to people and see how everyone else is doing and how other people feel," she explained. Her posts have resonated widely, drawing attention to the realities of living with a terminal diagnosis and the gaps in treatment access.
Now, Macpherson is campaigning for broader access to vorasidenib, a drug that can delay the need for aggressive chemotherapy and radiotherapy in certain brain tumor patients. The treatment is currently available through the NHS in Scotland, following approval by the Scottish Medicines Consortium, but has not yet been routinely funded in Wales, England, or Northern Ireland. The Welsh government told BBC News that it relies on independent advice from NICE (the National Institute for Health and Care Excellence) to ensure treatments are cost-effective. While clinical trials suggest vorasidenib can slow cancer progression, there is not yet clear evidence that it extends life, and NICE has provisionally recommended against making it widely available on the NHS—though final guidance is expected later this year.
For now, Macpherson accesses the drug through a private provider but worries that many other patients cannot afford this route. She is also undergoing fertility treatment before starting vorasidenib, as the therapy may affect her chances of having children in the future. Regular scans every three months will be needed to monitor her condition.
Her story also shines a light on the broader challenges facing brain tumor patients in the UK. According to Brain Tumour Research, these cancers are the leading cause of cancer-related death in people under 40 in Wales, yet they have received just 1% of UK cancer research funding since 2002. Organizations like Cancer Research UK and the Brain Tumour Charity continue to push for more investment in research and improved access to life-extending therapies.
Despite the daunting prognosis, Macpherson remains hopeful. "Medicine is excelling at a rate it has never done before, AI is taking over as we know, so I'm really hopeful on that front," she told BBC News. Her experience is a powerful reminder that sometimes, it takes a random, even painful, twist of fate to uncover a hidden truth—and that advocacy and awareness can turn personal tragedy into a force for change.